sativex 27+25 mg/ml mundhulespray, opløsning
jazz pharmaceuticals ireland ltd - cannabis ekstrakt (cbd), cannabis ekstrakt (thc) - mundhulespray, opløsning - 27+25 mg/ml
sativex 27+25 mg/ml mundhulespray, opl?sning
2care4 aps - cannabis ekstrakt (cbd), cannabis ekstrakt (thc) - mundhulespray, opløsning - 27+25 mg/ml
sativex 27+25 mg/ml mundhulespray, opløsning
orifarm a/s - cannabis ekstrakt (cbd), cannabis ekstrakt (thc) - mundhulespray, opløsning - 27+25 mg/ml
nyxthracis (previously obiltoxaximab sfl)
sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - immune sera og immunoglobuliner, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.
bediol 63 + 80 mg/g urtete
bedrocan b.v. - cannabidiol (cbd), cannabisblomst, dronabinol (thc) - urtete - 63 + 80 mg/g
bediol "canngros" 63 + 80 mg/g urtete
canngros aps - cannabidiol (cbd), cannabisblomst, dronabinol (thc) - urtete - 63 + 80 mg/g
bedrocan 220+<10 mg/g urtete
bedrocan b.v. - cannabidiol (cbd), cannabisblomst, dronabinol (thc) - urtete - 220+<10 mg/g
bedrocan "canngros" 220+<10 mg/g urtete
canngros aps - cannabidiol (cbd), cannabisblomst, dronabinol (thc) - urtete - 220+<10 mg/g
1:1 drops 12,5+12,5 mg/ml oral opløsning
canntrust inc - cannabidiol (cbd), dronabinol (thc), ekstrakt af cannabisblomst - oral opløsning - 12,5+12,5 mg/ml
1:1 drops "stenocare" 12,5+12,5 mg/ml oral opløsning
stenocare a/s - cannabidiol (cbd), dronabinol (thc), ekstrakt af cannabisblomst - oral opløsning - 12,5+12,5 mg/ml